InvestorsHub Logo
Followers 8
Posts 1929
Boards Moderated 0
Alias Born 09/10/2012

Re: None

Thursday, 04/21/2022 4:09:36 PM

Thursday, April 21, 2022 4:09:36 PM

Post# of 326
3.6. Initial applications in the decision-making phase
3.6.1. linzagolix choline - EMEA/H/C/005442
for the management of heavy menstrual bleeding (HMB) associated with uterine fibroids Scope: Revised opinion
Action: For adoption
List of Questions adopted on 24.02.2022. Opinion adopted on 16.12.2021. List of Outstanding Issues adopted on 11.11.2021, 16.09.2021. List of Questions adopted on 22.04.2021.
https://www.ema.europa.eu/en/documents/agenda/agenda-chmp-agenda-19-22-april-2022-meeting_en.pdf#page16